Trogarzo Now Approved Website
Brand: Trogarzo (ibalizumab-uiyk), Injection
Parent Company: Thera Technologies
Drug Type: Prescription
Drug Category: Infectious Diseases
Campaign: now-approved, PI-Only Launch
Targeting: HCPs, Patients
Patient Website:
HCP Website: http://trogarzo.com/